Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial
Clinical trial NCT02561455 · COMPLETED
Trial details
- NCT number
- NCT02561455
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-03
- Primary completion
- 2020-07-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.